A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
Public ClinicalTrials.gov record NCT05476926. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Real-World, Long-Term Data Collection to Gain Clinical Insights Into Roche Ophthalmology Products (VOYAGER STUDY)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The VOYAGER study is a primary data collection, non-interventional, prospective, multinational, multicenter study. It is designed to collect real-world, long-term data to explore long-term effectiveness, safety, clinical insights, treatment patterns, and factors driving the treatment decisions among patients being treated with specified Roche ophthalmology products in approved retinal indications (Faricimab for neovascular age-related macular degeneration \[nAMD\], diabetic macular edema \[DME\], and retinal vein occlusion; Port Delivery System with Ranibizumab for nAMD) in routine clinical practice. This study will not provide or make recommendations on use of any products including Roche products; treatment decisions will be determined by the treating physician and must be made independently to the decision to participate in this study. Participation in this study will not change or influence a patient's standard of care in any way.
Study identification
- NCT ID
- NCT05476926
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 6,000 participants
Conditions and interventions
Conditions
Interventions
- Faricimab Drug
- Port Delivery System with Ranibizumab Combination Product
Drug · Combination Product
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 20, 2022
- Primary completion
- Nov 29, 2026
- Completion
- Nov 29, 2027
- Last update posted
- Sep 1, 2026
2022 – 2027
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Research Institute, LLC | Phoenix | Arizona | 85014 | — |
| California Eye Specialists Medical group Inc. | Pasadena | California | 91107 | — |
| Retinal Consultants Medical Group | Sacramento | California | 95825 | — |
| Advanced Research | Coral Springs | Florida | 33067 | — |
| Retina Specialty Institute | Pensacola | Florida | 32503 | — |
| University Retina and Macula Associates, PC | Lemont | Illinois | 60439 | — |
| Springfield Clinic, Llp | Springfield | Illinois | 62703 | — |
| Retina Associates of Kentucky | Lexington | Kentucky | 40509 | — |
| Cumberland Valley Retina Consultants PC | Hagerstown | Maryland | 21740 | — |
| Associated Retinal Consultants PC | Royal Oak | Michigan | 48073 | — |
| Erie Retinal Surgery | Erie | Pennsylvania | 16507 | — |
| Tennessee Retina PC | Nashville | Tennessee | 37203 | — |
| Brown Retina Institute | San Antonio | Texas | 78251-4551 | — |
| Retina Center of Texas | Southlake | Texas | 76092-1352 | — |
| University of Utah, John Moran Eye Center | Salt Lake City | Utah | 84132 | — |
| Piedmont Eye Center | Lynchburg | Virginia | 24502 | — |
| Wagner Macula and Retina Center | Norfolk | Virginia | 23502-3933 | — |
| Spokane Eye Clinical Research | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 281 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05476926, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05476926 live on ClinicalTrials.gov.